1. Home
  2. CTNM vs NIPG Comparison

CTNM vs NIPG Comparison

Compare CTNM & NIPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTNM
  • NIPG
  • Stock Information
  • Founded
  • CTNM 2009
  • NIPG 2014
  • Country
  • CTNM United States
  • NIPG Sweden
  • Employees
  • CTNM N/A
  • NIPG N/A
  • Industry
  • CTNM
  • NIPG
  • Sector
  • CTNM
  • NIPG
  • Exchange
  • CTNM Nasdaq
  • NIPG NYSE
  • Market Cap
  • CTNM 453.0M
  • NIPG 398.2M
  • IPO Year
  • CTNM 2024
  • NIPG 2024
  • Fundamental
  • Price
  • CTNM $17.21
  • NIPG $5.90
  • Analyst Decision
  • CTNM Strong Buy
  • NIPG
  • Analyst Count
  • CTNM 4
  • NIPG 0
  • Target Price
  • CTNM $29.25
  • NIPG N/A
  • AVG Volume (30 Days)
  • CTNM 74.8K
  • NIPG 67.7K
  • Earning Date
  • CTNM 11-06-2024
  • NIPG 11-26-2024
  • Dividend Yield
  • CTNM N/A
  • NIPG N/A
  • EPS Growth
  • CTNM N/A
  • NIPG N/A
  • EPS
  • CTNM N/A
  • NIPG N/A
  • Revenue
  • CTNM N/A
  • NIPG $83,668,441.00
  • Revenue This Year
  • CTNM N/A
  • NIPG N/A
  • Revenue Next Year
  • CTNM N/A
  • NIPG N/A
  • P/E Ratio
  • CTNM N/A
  • NIPG N/A
  • Revenue Growth
  • CTNM N/A
  • NIPG 27.09
  • 52 Week Low
  • CTNM $13.27
  • NIPG $5.40
  • 52 Week High
  • CTNM $22.00
  • NIPG $17.76
  • Technical
  • Relative Strength Index (RSI)
  • CTNM N/A
  • NIPG N/A
  • Support Level
  • CTNM N/A
  • NIPG N/A
  • Resistance Level
  • CTNM N/A
  • NIPG N/A
  • Average True Range (ATR)
  • CTNM 0.00
  • NIPG 0.00
  • MACD
  • CTNM 0.00
  • NIPG 0.00
  • Stochastic Oscillator
  • CTNM 0.00
  • NIPG 0.00

About CTNM Contineum Therapeutics Inc. Class A Common Stock

Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.

About NIPG NIP GROUP INC SPON ADS EACH REPR 2 CL A ORD SHS

NIP Group Inc is a esports organization with operations across Asia, Europe and South America. It operate two esports brands: Ninjas in Pyjamas and eStar Gaming. Ninjas in Pyjamas, is a PC or console esports brand. eStar Gaming, is a mobile esports brand. The company has two reportable segments, including PRC and other entities, and Ninjas in Pyjamas. Key revenue is generated from PRC and other entities.

Share on Social Networks: